Presumably this has been discussed already, but I wanted to get some sense of how prevalent is the use of R for biostatistics publications. On PubMed I did find a number of research papers that were conducted using R (as mentioned in the Methods or Statistical Analysis sections of the documents). However, the majority were done using SAS/SPSS and also an appreciable number using Stata.
There has been a lot of talk about R in recent years and I am looking for some data that can corroborate the fact that R has been rising in popularity in the commercial area. In my experience, however, I have been seeing some resistance for firms to switch to R from SAS, even though there is so much more that you can do with R compared to SAS. There is also the concern that FDA "prefers results in SAS" ... although I have not seen anything officially mentioned by FDA to this effect.
I understand that SAS has been there for decades, it is what many R&D departments are most comfortable working with, etc., etc., ... and am looking for real-world examples of who are instead using R for professional research and/or publications.
R
is by far the most commonly used environment used by students today so just for publication purposes probably that won't be a problem. Major packages also are usually peer-revieed in the Journal of Statistical Software or similar publications. I don't know about professional research. (@Andre: U.S. Food and Drug Administration). $\endgroup$